nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—POLB—Base-free sugar-phosphate removal via the single-nucleotide replacement pathway—SMUG1—cervical cancer	0.0473	0.121	CbGpPWpGaD
Cytarabine—POLB—Resolution of AP sites via the single-nucleotide replacement pathway—SMUG1—cervical cancer	0.0409	0.105	CbGpPWpGaD
Cytarabine—POLB—Removal of DNA patch containing abasic residue—SMUG1—cervical cancer	0.0309	0.0791	CbGpPWpGaD
Cytarabine—POLB—Base Excision Repair—SMUG1—cervical cancer	0.0283	0.0724	CbGpPWpGaD
Cytarabine—POLD1—exocrine gland—cervical cancer	0.028	0.046	CbGeAlD
Cytarabine—NT5E—Differentiation Pathway—WNT2—cervical cancer	0.0166	0.0425	CbGpPWpGaD
Cytarabine—POLB—uterine cervix—cervical cancer	0.0148	0.0243	CbGeAlD
Cytarabine—POLB—decidua—cervical cancer	0.0141	0.0231	CbGeAlD
Cytarabine—NT5E—Differentiation Pathway—WNT5A—cervical cancer	0.0126	0.0322	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.0122	0.0311	CbGpPWpGaD
Cytarabine—POLD1—uterine cervix—cervical cancer	0.0121	0.0198	CbGeAlD
Cytarabine—DCTD—uterine cervix—cervical cancer	0.0119	0.0196	CbGeAlD
Cytarabine—POLD1—Removal of DNA patch containing abasic residue—SMUG1—cervical cancer	0.0119	0.0303	CbGpPWpGaD
Cytarabine—DCTD—decidua—cervical cancer	0.0114	0.0187	CbGeAlD
Cytarabine—POLD1—renal system—cervical cancer	0.0113	0.0186	CbGeAlD
Cytarabine—CDA—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.0112	0.0287	CbGpPWpGaD
Cytarabine—DCTD—renal system—cervical cancer	0.0112	0.0183	CbGeAlD
Cytarabine—POLB—female reproductive system—cervical cancer	0.0111	0.0182	CbGeAlD
Cytarabine—POLD1—Base Excision Repair—SMUG1—cervical cancer	0.0108	0.0277	CbGpPWpGaD
Cytarabine—CDA—uterine cervix—cervical cancer	0.0108	0.0178	CbGeAlD
Cytarabine—DCTD—endometrium—cervical cancer	0.0108	0.0177	CbGeAlD
Cytarabine—DCTD—mammalian vulva—cervical cancer	0.0104	0.0171	CbGeAlD
Cytarabine—CDA—decidua—cervical cancer	0.0103	0.017	CbGeAlD
Cytarabine—POLD1—Global Genomic NER (GG-NER)—ERCC1—cervical cancer	0.0103	0.0262	CbGpPWpGaD
Cytarabine—POLB—DNA Repair—ERCC1—cervical cancer	0.0102	0.0262	CbGpPWpGaD
Cytarabine—POLB—female gonad—cervical cancer	0.0101	0.0166	CbGeAlD
Cytarabine—POLD1—uterus—cervical cancer	0.0101	0.0165	CbGeAlD
Cytarabine—POLB—vagina—cervical cancer	0.01	0.0165	CbGeAlD
Cytarabine—DCTD—uterus—cervical cancer	0.00993	0.0163	CbGeAlD
Cytarabine—POLE—Global Genomic NER (GG-NER)—ERCC1—cervical cancer	0.00991	0.0253	CbGpPWpGaD
Cytarabine—CDA—endometrium—cervical cancer	0.00981	0.0161	CbGeAlD
Cytarabine—CDA—mammalian vulva—cervical cancer	0.00949	0.0156	CbGeAlD
Cytarabine—NT5E—epithelium—cervical cancer	0.0093	0.0153	CbGeAlD
Cytarabine—NT5E—uterine cervix—cervical cancer	0.00922	0.0151	CbGeAlD
Cytarabine—POLD1—female reproductive system—cervical cancer	0.00905	0.0149	CbGeAlD
Cytarabine—POLE—uterine cervix—cervical cancer	0.00903	0.0148	CbGeAlD
Cytarabine—DCTD—female reproductive system—cervical cancer	0.00893	0.0147	CbGeAlD
Cytarabine—NT5E—decidua—cervical cancer	0.00879	0.0144	CbGeAlD
Cytarabine—NT5E—renal system—cervical cancer	0.00863	0.0142	CbGeAlD
Cytarabine—POLE—decidua—cervical cancer	0.00861	0.0141	CbGeAlD
Cytarabine—NT5E—endometrium—cervical cancer	0.00834	0.0137	CbGeAlD
Cytarabine—POLD1—female gonad—cervical cancer	0.00824	0.0135	CbGeAlD
Cytarabine—POLD1—Transcription-coupled NER (TC-NER)—ERCC1—cervical cancer	0.0082	0.021	CbGpPWpGaD
Cytarabine—POLE—endometrium—cervical cancer	0.00817	0.0134	CbGeAlD
Cytarabine—DCTD—female gonad—cervical cancer	0.00813	0.0133	CbGeAlD
Cytarabine—DCTD—vagina—cervical cancer	0.00808	0.0133	CbGeAlD
Cytarabine—NT5E—mammalian vulva—cervical cancer	0.00807	0.0132	CbGeAlD
Cytarabine—POLE—Transcription-coupled NER (TC-NER)—ERCC1—cervical cancer	0.00792	0.0202	CbGpPWpGaD
Cytarabine—POLE—mammalian vulva—cervical cancer	0.0079	0.013	CbGeAlD
Cytarabine—CDA—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00786	0.0201	CbGpPWpGaD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00779	0.0199	CbGpPWpGaD
Cytarabine—POLA1—uterine cervix—cervical cancer	0.00779	0.0128	CbGeAlD
Cytarabine—NT5E—uterus—cervical cancer	0.00769	0.0126	CbGeAlD
Cytarabine—POLD1—Nucleotide Excision Repair—ERCC1—cervical cancer	0.00753	0.0193	CbGpPWpGaD
Cytarabine—POLA1—decidua—cervical cancer	0.00742	0.0122	CbGeAlD
Cytarabine—CDA—vagina—cervical cancer	0.00735	0.0121	CbGeAlD
Cytarabine—POLE—Nucleotide Excision Repair—ERCC1—cervical cancer	0.00728	0.0186	CbGpPWpGaD
Cytarabine—POLA1—endometrium—cervical cancer	0.00704	0.0116	CbGeAlD
Cytarabine—NT5E—female reproductive system—cervical cancer	0.00691	0.0113	CbGeAlD
Cytarabine—POLA1—mammalian vulva—cervical cancer	0.00681	0.0112	CbGeAlD
Cytarabine—POLB—DNA Repair—SMUG1—cervical cancer	0.0068	0.0174	CbGpPWpGaD
Cytarabine—POLE—female reproductive system—cervical cancer	0.00677	0.0111	CbGeAlD
Cytarabine—POLB—lymph node—cervical cancer	0.00648	0.0106	CbGeAlD
Cytarabine—NT5E—female gonad—cervical cancer	0.00629	0.0103	CbGeAlD
Cytarabine—NT5E—vagina—cervical cancer	0.00625	0.0103	CbGeAlD
Cytarabine—POLE—female gonad—cervical cancer	0.00616	0.0101	CbGeAlD
Cytarabine—POLE—vagina—cervical cancer	0.00612	0.0101	CbGeAlD
Cytarabine—POLA1—E2F transcription factor network—YY1—cervical cancer	0.00594	0.0152	CbGpPWpGaD
Cytarabine—NT5E—Differentiation Pathway—NOTCH1—cervical cancer	0.00547	0.014	CbGpPWpGaD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00545	0.0139	CbGpPWpGaD
Cytarabine—SLC22A2—renal system—cervical cancer	0.00542	0.0089	CbGeAlD
Cytarabine—POLD1—Extension of Telomeres—TERT—cervical cancer	0.00539	0.0138	CbGpPWpGaD
Cytarabine—POLA1—female gonad—cervical cancer	0.00531	0.00872	CbGeAlD
Cytarabine—POLD1—lymph node—cervical cancer	0.0053	0.0087	CbGeAlD
Cytarabine—POLA1—vagina—cervical cancer	0.00528	0.00866	CbGeAlD
Cytarabine—DCTD—lymph node—cervical cancer	0.00522	0.00858	CbGeAlD
Cytarabine—POLE—Extension of Telomeres—TERT—cervical cancer	0.00521	0.0133	CbGpPWpGaD
Cytarabine—SLC29A1—uterine cervix—cervical cancer	0.00503	0.00825	CbGeAlD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.00492	0.0126	CbGpPWpGaD
Cytarabine—DCK—uterine cervix—cervical cancer	0.0048	0.00788	CbGeAlD
Cytarabine—SLC29A1—decidua—cervical cancer	0.00479	0.00786	CbGeAlD
Cytarabine—CDA—lymph node—cervical cancer	0.00475	0.00781	CbGeAlD
Cytarabine—SLC29A1—renal system—cervical cancer	0.0047	0.00772	CbGeAlD
Cytarabine—DCK—decidua—cervical cancer	0.00457	0.00751	CbGeAlD
Cytarabine—ABCC10—uterine cervix—cervical cancer	0.00457	0.00751	CbGeAlD
Cytarabine—SLC29A1—endometrium—cervical cancer	0.00454	0.00746	CbGeAlD
Cytarabine—SLC29A1—mammalian vulva—cervical cancer	0.0044	0.00722	CbGeAlD
Cytarabine—ABCC10—decidua—cervical cancer	0.00436	0.00716	CbGeAlD
Cytarabine—DCK—endometrium—cervical cancer	0.00434	0.00713	CbGeAlD
Cytarabine—ABCC10—renal system—cervical cancer	0.00428	0.00703	CbGeAlD
Cytarabine—DCK—mammalian vulva—cervical cancer	0.0042	0.0069	CbGeAlD
Cytarabine—SLC29A1—uterus—cervical cancer	0.00419	0.00688	CbGeAlD
Cytarabine—ABCC10—endometrium—cervical cancer	0.00414	0.00679	CbGeAlD
Cytarabine—NT5E—lymph node—cervical cancer	0.00404	0.00664	CbGeAlD
Cytarabine—ABCC10—mammalian vulva—cervical cancer	0.004	0.00657	CbGeAlD
Cytarabine—DCK—uterus—cervical cancer	0.004	0.00657	CbGeAlD
Cytarabine—POLE—lymph node—cervical cancer	0.00396	0.0065	CbGeAlD
Cytarabine—POLD1—DNA Repair—ERCC1—cervical cancer	0.00392	0.01	CbGpPWpGaD
Cytarabine—SLC22A1—renal system—cervical cancer	0.00383	0.00629	CbGeAlD
Cytarabine—ABCC10—uterus—cervical cancer	0.00381	0.00626	CbGeAlD
Cytarabine—POLE—DNA Repair—ERCC1—cervical cancer	0.00379	0.00969	CbGpPWpGaD
Cytarabine—SLC29A1—female reproductive system—cervical cancer	0.00376	0.00618	CbGeAlD
Cytarabine—POLA1—Extension of Telomeres—TERT—cervical cancer	0.00371	0.00949	CbGpPWpGaD
Cytarabine—DCK—female reproductive system—cervical cancer	0.0036	0.00591	CbGeAlD
Cytarabine—ABCC10—female reproductive system—cervical cancer	0.00343	0.00563	CbGeAlD
Cytarabine—SLC29A1—female gonad—cervical cancer	0.00343	0.00563	CbGeAlD
Cytarabine—POLA1—lymph node—cervical cancer	0.00341	0.0056	CbGeAlD
Cytarabine—SLC29A1—vagina—cervical cancer	0.00341	0.00559	CbGeAlD
Cytarabine—DCK—female gonad—cervical cancer	0.00327	0.00537	CbGeAlD
Cytarabine—DCK—vagina—cervical cancer	0.00325	0.00534	CbGeAlD
Cytarabine—ABCC10—female gonad—cervical cancer	0.00312	0.00512	CbGeAlD
Cytarabine—ABCC10—vagina—cervical cancer	0.0031	0.00509	CbGeAlD
Cytarabine—CDA—Fluoropyrimidine Activity—TP53—cervical cancer	0.00299	0.00763	CbGpPWpGaD
Cytarabine—SLC22A1—vagina—cervical cancer	0.00277	0.00456	CbGeAlD
Cytarabine—POLD1—DNA Repair—SMUG1—cervical cancer	0.0026	0.00666	CbGpPWpGaD
Cytarabine—POLE—DNA Repair—SMUG1—cervical cancer	0.00252	0.00643	CbGpPWpGaD
Cytarabine—POLD1—Telomere Maintenance—TERT—cervical cancer	0.00244	0.00625	CbGpPWpGaD
Cytarabine—POLE—Telomere Maintenance—TERT—cervical cancer	0.00236	0.00604	CbGpPWpGaD
Cytarabine—SLC29A1—lymph node—cervical cancer	0.0022	0.00362	CbGeAlD
Cytarabine—DCK—lymph node—cervical cancer	0.0021	0.00346	CbGeAlD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—TP53—cervical cancer	0.00207	0.00529	CbGpPWpGaD
Cytarabine—POLD1—Chromosome Maintenance—TERT—cervical cancer	0.00204	0.00521	CbGpPWpGaD
Cytarabine—ABCC10—lymph node—cervical cancer	0.002	0.00329	CbGeAlD
Cytarabine—POLE—Chromosome Maintenance—TERT—cervical cancer	0.00197	0.00503	CbGpPWpGaD
Cytarabine—CYP3A4—renal system—cervical cancer	0.00175	0.00287	CbGeAlD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00173	0.00441	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CA9—cervical cancer	0.00168	0.00431	CbGpPWpGaD
Cytarabine—POLA1—Telomere Maintenance—TERT—cervical cancer	0.00168	0.0043	CbGpPWpGaD
Cytarabine—POLA1—Chromosome Maintenance—TERT—cervical cancer	0.0014	0.00358	CbGpPWpGaD
Cytarabine—CYP3A4—female reproductive system—cervical cancer	0.0014	0.0023	CbGeAlD
Cytarabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00125	0.0032	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.0012	0.00308	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—TP53—cervical cancer	0.001	0.00256	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CA9—cervical cancer	0.000967	0.00247	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CA9—cervical cancer	0.000885	0.00226	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.000823	0.00211	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.000802	0.00205	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—MTHFR—cervical cancer	0.000683	0.00175	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000645	0.00165	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.000587	0.0015	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CA9—cervical cancer	0.000549	0.0014	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TERT—cervical cancer	0.000517	0.00132	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CA9—cervical cancer	0.000516	0.00132	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TERT—cervical cancer	0.000499	0.00128	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000488	0.00125	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.00047	0.0012	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—MTHFR—cervical cancer	0.000392	0.001	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000373	0.000953	CbGpPWpGaD
Cytarabine—CDA—Metabolism—MTHFR—cervical cancer	0.000359	0.000918	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TERT—cervical cancer	0.000356	0.000909	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000313	0.0008	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—MTHFR—cervical cancer	0.000223	0.000569	CbGpPWpGaD
Cytarabine—DCK—Metabolism—MTHFR—cervical cancer	0.000209	0.000535	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CA9—cervical cancer	0.000204	0.000522	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—cervical cancer	0.000197	0.000503	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CA9—cervical cancer	0.00019	0.000487	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—cervical cancer	0.00019	0.000486	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—cervical cancer	0.000135	0.000346	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MTHFR—cervical cancer	8.29e-05	0.000212	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MTHFR—cervical cancer	7.73e-05	0.000198	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CA9—cervical cancer	6.88e-05	0.000176	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MTHFR—cervical cancer	2.79e-05	7.13e-05	CbGpPWpGaD
